Search Within

Dermatology Service

Formats
  1. Journal Article (1271)
  2. Meeting Abstract (451)
  3. Book Section (152)
  4. Conference Paper (92)
  5. Research Letter (91)
  6. Review (91)
  7. Editorial (45)
  8. Correspondence (31)
  9. Guidelines (18)
  10. Book Whole (16)
  11. Miscellaneous (15)
Groups
  1. Department of Medicine (2260)
  2. Dermatology (2260)
  3. Division of Subspecialty Medicine (2260)
  4. Survivorship Research (1334)
  5. Melanoma Disease Management Team (676)
  6. Population Sciences Research Program (547)

More Groups

People
  1. Ashfaq Marghoob (541)
  2. Mario Lacouture (457)
  3. Allan Halpern (400)
  4. Kishwer Nehal (280)
  5. Stephen Dusza (279)
  6. Anthony Rossi (243)

More People

Years
  1. 2025 (61)
  2. 2024 (125)
  3. 2023 (121)
  4. 2022 (159)
  5. 2021 (140)
  6. 2020 (117)

More Years

Publications
  1. Journal of the American Academy of Dermatology (351)
  2. Journal of Investigative Dermatology (121)
  3. Journal of Clinical Oncology (114)
  4. JAMA Dermatology (94)
  5. Dermatologic Surgery (85)
  6. Archives of Dermatology (68)

More Publications

Publishers
  1. Mosby Elsevier (356)
  2. American Medical Association (169)
  3. Wiley Blackwell (162)
  4. Springer (152)
  5. Elsevier Science, Inc. (147)
  6. Lippincott Williams & Wilkins (135)

More Publishers

Results (2273)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS
    Meeting Abstract

    George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab
    Meeting Abstract

    Ghione, P.; Joffe, E.; De Paola, N.; Mainardi, T.; Noor, S. J.; Bobillo, S.; Myskowski, P. L.; Palomba, M. L.; Moskowitz, A. J.; Mato, A. R.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Cutaneous pigmentary changes related to anticancer therapy in African Americans
    Meeting Abstract

    Barrios, D. M.; Noor, S. J.; Lacouture, M. E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients
    Meeting Abstract

    Barrios, D. M.; Wang, D. G.; Blinder, V. S.; Bromberg, J.; Drullinsky, P.; Funt, S. A.; Jhaveri, K. L.; Lake, D.; Lyons, T.; Modi, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • EPIK-B2: A phase III study of alpelisib (ALP) as maintenance therapy with trastuzumab (T) and pertuzumab (P) in patients (pts) with PIK3CA-mutated (mut) human epidermal growth factor receptor-2-positive (HER2+) advanced breast cancer (ABC)
    Meeting Abstract

    Hurvitz, S. A.; Chia, S. K. L.; Ciruelos, E. M.; Hu, X.; Im, S. A.; Janni, W.; Jerusalem, G.; Lacouture, M.; O'Regan, R.; Rugo, H. S.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Cutaneous manifestations of EGFR-inhibitors in African Americans and treatment considerations
    Journal Article

    Geisler, A. N.; Noor, S. J.
    Journal of Drugs in Dermatology (2020)

    Fulltext@MSK | Save
  • Incompletely excised lentigo maligna melanoma is associated with unpredictable residual disease: Clinical features and the emerging role of reflectance confocal microscopy
    Journal Article

    Navarrete-Dechent, C.; Aleissa, S.; Cordova, M.; Liopyris, K.; Lee, E. H.; Rossi, A. M.; Hollman, T.; Pulitzer, M.; Lezcano, C.; Busam, K. J.; more...
    Journal of the European Academy of Dermatology and Venereology (2020)

    Fulltext@MSK | Save
  • A retrospective multicenter study of fatal pediatric melanoma
    Journal Article

    Hawryluk, E. B.; Moustafa, D.; Bartenstein, D.; Brahmbhatt, M.; Cordoro, K.; Gardner, L.; Gauthier, A.; Grossman, D.; Gupta, D.; Hunt, R. D.; more...
    Journal of the American Academy of Dermatology (2020)

    Fulltext@MSK | Save
  • Treatment of severe cutaneous adverse reaction with tocilizumab
    Research Letter

    Hibler, B. P.; Markova, A.
    British Journal of Dermatology (2020)

    Fulltext@MSK | Save
  • Cost-benefit implication of gene expression profiling and adjuvant therapy in stage IIIA melanoma
    Journal Article

    Hu, Y.; Briggs, A.; Marchetti, M. A.; Ariyan, C. E.; Coit, D. G.; Bartlett, E. K.
    Journal of the American College of Surgeons (2020)

    Fulltext@MSK | Save